No Data
No Data
J&J-backed HistoSonics Explores Sale at $2.5 Billion Valuation, FT Reports
Research Alert: CFRA Keeps Hold Opinion On Shares Of Ge Healthcare Technologies Inc.
BofA Securities Maintains GE HealthCare Technologies(GEHC.US) With Hold Rating, Cuts Target Price to $82
Wells Fargo Maintains GE HealthCare Technologies(GEHC.US) With Buy Rating, Cuts Target Price to $89
Jefferies Maintains GE HealthCare Technologies(GEHC.US) With Buy Rating, Cuts Target Price to $95
GE HealthCare's Strong Q1 Took Back Seat To Tariffs, Analyst Sees 2026 Tariff Impact Less Than 2025